Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in

Jakub Neradil1,2, Michal Kyr2, Kristyna Polaskova2

  • 1Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.

Frontiers in Oncology
|October 17, 2019
PubMed

Insights

Phospho-protein arrays offer a promising approach for personalized pediatric cancer treatment by analyzing tumor signaling pathways. This method helps identify druggable targets, potentially improving outcomes for relapsed or refractory solid tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Personalized Medicine

Background:

  • Targeting signal transduction pathways is a key strategy in pediatric oncology.
  • Low-molecular-weight inhibitors and monoclonal antibodies are promising therapeutic agents.
  • Personalized treatment requires detailed molecular profiling of tumors.

Purpose of the Study:

  • To evaluate the clinical utility of phospho-protein arrays for analyzing tumor signaling in pediatric oncology.
  • To systematically assess the advantages and limitations of phospho-protein arrays in personalized medicine.
  • To demonstrate the application of phospho-protein arrays for identifying druggable targets in pediatric solid tumors.

Main Methods:

  • Utilized commercially available phospho-protein arrays to analyze phosphorylation profiles of receptor tyrosine kinases and downstream signaling proteins.
  • Performed systematic analysis of data processing, evaluation, and validation using immunohistochemistry.
  • Applied phospho-protein arrays for single and serial sample analyses and hierarchical clustering of pediatric solid tumors.

Main Results:

  • Demonstrated successful and clinically relevant use of phospho-protein arrays for profiling tumor tissue samples.
  • Identified key aspects of data processing, evaluation, and validation for clinical application.
  • Showcased the potential for hierarchical clustering of pediatric solid tumors based on phosphorylation profiles.

Conclusions:

  • Phospho-protein arrays are valuable tools for identifying druggable molecular targets in specific tumors.
  • Validation of phospho-protein arrays for diagnostic purposes can significantly enhance personalized treatment for relapsed or refractory pediatric solid tumors.
  • This approach holds potential to improve therapeutic strategies in pediatric oncology.